Returns–Not enough quarters yet
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| BCAXBicara Therapeutics Inc. | $54.1M | 29.1% | −23.8% |
| NUVBNuvation Bio Inc. | $45.9M | 24.7% | |
| Kestra Med Technologies LtdCUSIP G52441105 | $26.0M | 14.0% | |
| BBOTBridgeBio Oncology Therapeutics Inc. | $25.1M | 13.5% | |
| BBNXBeta Bionics Inc. | $20.6M | 11.1% | |
| ALMSAlumis Inc. | $6.8M | 3.7% | |
| SANASana Biotechnology, Inc. | $2.9M | 1.6% | |
| IMAImageneBio, Inc. | $2.7M | 1.4% | |
| enGene Holdings Inc.CUSIP 29286M105 | $1.5M | 0.8% | |
| ODTXOdyssey Therapeutics Inc. | $54K | 0.0% | New |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| ALMSAlumis Inc. | June 30, 2024 | +111.6% | $6.8M |
| BCAXBicara Therapeutics Inc. | September 30, 2024 | +16.6% | $54.1M |
| Kestra Med Technologies LtdCUSIP G52441105 | March 31, 2025 | +2.1% | $26.0M |
| IMAImageneBio, Inc. | September 30, 2025 | −27.6% | $2.7M |
| BBOTBridgeBio Oncology Therapeutics Inc. | September 30, 2025 | −34.2% | $25.1M |
| NUVBNuvation Bio Inc. | March 31, 2021 | −45.6% | $45.9M |
| SANASana Biotechnology, Inc. | March 31, 2021 | −89.6% | $2.9M |
Sold off last quarter
- REPLReplimune Group was $1.9M
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +29.7% | +14.8% |
| December 31, 2025 | +42.4% | +2.4% |
| September 30, 2025 | +45.1% | +7.8% |
| June 30, 2025 | −5.1% | +10.5% |
| March 31, 2025 | −34.9% | −4.6% |
| December 31, 2024 | −13.4% | +2.1% |
| September 30, 2024 | −5.1% | +5.4% |
| June 30, 2024 | −12.3% | +4.0% |
| March 31, 2024 | +43.8% | +10.0% |
| December 31, 2023 | −20.5% | +11.2% |
| September 30, 2023 | −25.3% | −3.6% |
| June 30, 2023 | +31.2% | +8.3% |
| December 31, 2022 | +28.7% | +7.1% |
| September 30, 2022 | +2.2% | −5.3% |
| June 30, 2022 | −24.1% | −16.5% |
| March 31, 2022 | −32.2% | −4.9% |
| December 31, 2021 | −11.6% | +10.7% |
| September 30, 2021 | −5.1% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Omega Fund Management, LLC Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1637359&type=13F-HR&dateb=&owner=include&count=40CIK 1637359
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1637359/000119312526350681/Filed August 14, 2026 · accession 0001193125-26-350681